These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17964918)
1. Medical therapy for obesity--current status and future hopes. Bray GA Med Clin North Am; 2007 Nov; 91(6):1225-53, xi. PubMed ID: 17964918 [TBL] [Abstract][Full Text] [Related]
2. Medications for weight reduction. Bray GA Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940 [TBL] [Abstract][Full Text] [Related]
3. A critical review of the cannabinoid receptor as a drug target for obesity management. Akbas F; Gasteyger C; Sjödin A; Astrup A; Larsen TM Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231 [TBL] [Abstract][Full Text] [Related]
4. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Kennett GA; Clifton PG Pharmacol Biochem Behav; 2010 Nov; 97(1):63-83. PubMed ID: 20688100 [TBL] [Abstract][Full Text] [Related]
6. Challenges in the discovery and development of new agents for the treatment of obesity. Staten MA Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527 [TBL] [Abstract][Full Text] [Related]
7. The promise of ghrelin antagonism in obesity treatment. Helmling S; Jarosch F; Klussmann S Drug News Perspect; 2006; 19(1):13-20. PubMed ID: 16550252 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic therapy for obesity. Udall JN; Licciardi DM; Svec F J La State Med Soc; 2005 Jan; 157 Spec No 1():S56-64. PubMed ID: 15751911 [TBL] [Abstract][Full Text] [Related]
9. Treatment modalities of obesity: what fits whom? Hainer V; Toplak H; Mitrakou A Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical approaches to the treatment of obesity. Jandacek RJ; Woods SC Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320 [TBL] [Abstract][Full Text] [Related]
11. Drug treatment of obesity. Bray GA Psychiatr Clin North Am; 2005 Mar; 28(1):193-217, ix-x. PubMed ID: 15733619 [No Abstract] [Full Text] [Related]
12. Another type of intervention: treating obesity with medication. Greenway F J Am Diet Assoc; 2005 Jun; 105(6):895-8. PubMed ID: 15942538 [No Abstract] [Full Text] [Related]
13. [Novel anti-obesity drugs]. Tripp B; Ludvik B Acta Med Austriaca; 2004; 31(4):133-8. PubMed ID: 15732249 [TBL] [Abstract][Full Text] [Related]
14. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges. Hutchinson NI; Ryder SW Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723 [TBL] [Abstract][Full Text] [Related]
15. Companies throw their weight behind new antiobesity drugs. Cahoon L Nat Med; 2010 Feb; 16(2):136. PubMed ID: 20134442 [No Abstract] [Full Text] [Related]
16. Pharmaceutical treatment of obesity. Blackburn GL; Miller D; Chan S Nurs Clin North Am; 1997 Dec; 32(4):831-48. PubMed ID: 9386228 [TBL] [Abstract][Full Text] [Related]
17. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes. Jordan J; Schlaich M; Redon J; Narkiewicz K; Luft FC; Grassi G; Dixon J; Lambert G; Engeli S; ; J Hypertens; 2011 Feb; 29(2):189-93. PubMed ID: 21178784 [No Abstract] [Full Text] [Related]
18. The discovery of taranabant, a selective cannabinoid-1 receptor inverse agonist for the treatment of obesity. Hagmann WK Arch Pharm (Weinheim); 2008 Jul; 341(7):405-11. PubMed ID: 18574849 [TBL] [Abstract][Full Text] [Related]
19. Dietary supplements for weight loss: challenges in evaluation. Allison DB Obes Rev; 2005 May; 6(2):89-92. PubMed ID: 15836458 [No Abstract] [Full Text] [Related]
20. The good and the bad news: surgery vs. drug therapy. Astrup A Obes Rev; 2008 Jan; 9(1):1-3. PubMed ID: 18154599 [No Abstract] [Full Text] [Related] [Next] [New Search]